Trial Profile
A phase I placebo controlled, double blind, randomized, single ascending-dose study investigating pharmacokinetics, pharmacodynamics, safety, and tolerability of Vedolizumab in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 14 Nov 2016 Status changed from not stated to completed.
- 14 Nov 2016 New trial record
- 01 Nov 2016 Results published in the Clinical Drug Investigation